Point72 Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5M | Sell |
848,549
-300,862
| -26% | -$8.32M | 0.05% | 376 |
|
|
2025
Q1 | $25.5M | Buy |
+1,149,411
| New | +$25.5M | 0.06% | 336 |
|
|
2022
Q2 | – | Sell |
-329,798
| Closed | -$3.28M | – | 1192 |
|
|
2022
Q1 | $3.28M | Sell |
329,798
-68,554
| -17% | -$681K | 0.01% | 712 |
|
|
2021
Q4 | $4.69M | Buy |
398,352
+23,252
| +6% | +$274K | 0.02% | 645 |
|
|
2021
Q3 | $4.27M | Buy |
+375,100
| New | +$4.27M | 0.02% | 641 |
|
|
2021
Q2 | – | Sell |
-219,800
| Closed | -$4.07M | – | 1015 |
|
|
2021
Q1 | $4.07M | Buy |
+219,800
| New | +$4.07M | 0.02% | 572 |
|
|
2019
Q4 | – | Sell |
-140,000
| Closed | -$1.19M | – | 1050 |
|
|
2019
Q3 | $1.19M | Buy |
140,000
+105,000
| +300% | +$893K | 0.01% | 607 |
|
|
2019
Q2 | $474K | Buy |
+35,000
| New | +$474K | ﹤0.01% | 761 |
|
|
2018
Q3 | – | Sell |
-5,000
| Closed | -$87K | – | 949 |
|
|
2018
Q2 | $87K | Buy |
+5,000
| New | +$87K | ﹤0.01% | 772 |
|